Boost Your Productivity!Translate documents (Ms-Word, Ms-Excel, ...) faster and better thanks to artificial intelligence!

Discover ChatGPT for Translators

Vertaling van "clinical and health " (Frans → Nederlands) :

La recherche de directives sur les “evidence based websites” classiques (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) avec les termes de recherche “ ‘pneumonia’ and ‘nursing home’ “ ne donne aucun résultat.

http://www.farmaka.be/fr/formu (...) (...) [HTML]

Zoeken op de klassieke evidence based websites voor richtlijnen (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) met de zoekterm “ ‘pneumonia’ and ‘nursing home’ “ levert geen resultaat op.

http://www.farmaka.be/fr/formu (...) (...) [HTML]

http://www.farmaka.be/nl/genee (...) [HTML]

[La Revue Prescrire 2010; 30:555-6; 2011; 31: 209-10 et 2012; 32:729; Drug Ther Bulletin 2012; 10:117-20 (doi:10.1136/dtb.2012.10.0136); National Institute for Health and Clinical Excellence: NICE Clinical guidelines CG126, juillet 2011via www.nice.org.uk/CG126; NICE technology appraisal guidance 267, novembre 2012 via www.nice.org.uk/TA267; Pharma Selecta 2010; 26 :112-8]

http://www.cbip.be/PDF/Folia/2 (...) (...) [HTML]

[La Revue Prescrire 2010; 30:555-6; 2011; 31:209-10 en 2012; 32:729; Drug Ther Bulletin 2012; 10:117-20 (doi:10.1136/ dtb.2012.10.0136); National Institute for Health and Clinical Excellence: NICE Clinical guidelines CG126, juli 2011 via www.nice.org.uk/ CG126; NICE technology appraisal guidance 267, november 2012 via www.nice.org.uk/ TA267; Pharma Selecta 2010; 26:112-8]

http://www.cbip.be/PDF/Folia/2 (...) (...) [HTML]

http://www.bcfi.be/PDF/Folia/2 (...) [HTML]

CD005429 (doi:10.1002/14651858.CD005429.pub2.); National Institute for Health and Clinical Excellence : NICE clinical guidance CG40, octobre 2006 via www.nice.org.uk/CG40; PlosOne 2011; 6 :e16718]

http://www.cbip.be/PDF/Folia/2 (...) (...) [HTML]

CD005429 (doi:10.1002/14651858.CD005429.pub2.); National Institute for Health and Clinical Excellence : NICE clinical guidance CG40, oktober 2006 via www.nice.org.uk/CG40; Plos One 2011; 6:e16718]

http://www.cbip.be/PDF/Folia/2 (...) (...) [HTML]

http://www.bcfi.be/PDF/Folia/2 (...) [HTML]

° Canadian Medical Association (Clinical Practice Guidelines) ° Canadian Task Force on Preventive Health Care ° Clinical practice guidelines (Guidelines Advisory Committee Ontario)

http://www.farmaka.be/portail_ (...) (...) [HTML]

° Canadian Medical Association [Clinical Practice Guidelines] ° Canadian Task Force on Preventive Health Care ° Clinical practice guidelines [Guidelines Advisory Committee Ontario]

http://www.farmaka.be/portail_ (...) (...) [HTML]

http://www.farmaka.be/ebm_port (...) [HTML]

° SIGN (Scottish Intercollegiate Guidelines Network) ° Prodigy / Klinical knowledge summaries (NHS) (Department of Health) ° NICE (National Institute for Clinical Excellence) ° Centre for Evidence-Based Mental Health ° Royal College of Nursing

http://www.farmaka.be/portail_ (...) (...) [HTML]

° SIGN [Scottish Intercollegiate Guidelines Network] ° NICE CKS [Clinical Knowledge Summaries] ° NICE [National Institute for Clinical Excellence] ° Centre for Evidence-Based Mental Health ° Royal College of Nursing

http://www.farmaka.be/portail_ (...) (...) [HTML]

http://www.farmaka.be/ebm_port (...) [HTML]

° CEBAM le Centre belge pour l´Evidence-Based Medicine ° Trip-database - Recherche dans un soixantaine de sources EBM ° Prime Answers (University of Washington Health Sciences Libraries) ° PubMed Clinical Queries - Chercher avec des filtres méthodologiques - Chercher des revues systhématiques et des méta-analyses ° Sumsearch (National Electronical Library for Health UK)

http://www.farmaka.be/portail_ (...) (...) [HTML]

° ° CEBAM Belgisch Centrum voor Evidence-Based Medicine ° ° Trip-database - Megasearch in 60-tal EBM bronnen ° ° PubMed Clinical Queries ° - Zoeken met reeds ingestelde methodologische filters ° - Zoeken naar systematische reviews en meta-analyses ° Google Scholar

http://www.farmaka.be/portail_ (...) (...) [HTML]

http://www.farmaka.be/ebm_port (...) [HTML]

Mise à jour – Clinical Evidence – Cochrane – Minerva – Health Technology Assessments – Méta-analyses (Lancet, BMJ)

http://www.farmaka.be/fr/visit (...) (...) [HTML]

Update aan de hand van – Clinical Evidence – Cochrane – Minerva – Health Technology Assessments – Meta-analyses (Lancet, BMJ)

http://www.farmaka.be/fr/visit (...) (...) [HTML]

http://www.farmaka.be/nl/artse (...) [HTML]

Gauthier K, Bai A, Perras C et al ; Canadian Agency for Drugs and Technologies in Health. Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis : clinical effectiveness and harms.

http://www.farmaka.be/fr/formu (...) (...) [HTML]

postmenopausal osteoporosis : clinical effectiveness and harms.

http://www.farmaka.be/fr/formu (...) (...) [HTML]

http://www.farmaka.be/nl/wzc_f (...) [HTML]

D’après les recommandations récentes du National Institute for Health and Clinical Excellence (NICE), l’ivabradine peut être envisagée chez les patients atteints d’une insuffisance cardiaque chronique stable (classe NYHA de II à IV; fraction d’éjection ≤ 35%) avec une fréquence cardiaque ≥ 75 battements/minute malgré un traitement standard optimalisé (β-bloquants, IECA, antagonistes de l’aldostérone) ou en cas de contre-indication ou d’intolérance aux β-bloquants.

http://www.cbip.be/PDF/Folia/2 (...) (...) [HTML]

Volgens de recente aanbevelingen van het National Institute for Health and Clinical Excellence (NICE) kan ivabradine overwogen worden bij patiënten met chronisch stabiel hartfalen (NYHA II tot IV; ejectiefractie ≤ 35 %) met hartfrequentie ≥ 75 slagen/minuut ondanks een optimale standaardbehandeling (β-blokkers, ACE-inhibitoren, aldosteronantagonisten) of wanneer β-blokkers gecontraindiceerd zijn of niet verdragen worden.

http://www.cbip.be/PDF/Folia/2 (...) (...) [HTML]

http://www.bcfi.be/PDF/Folia/2 (...) [HTML]

National Insititute for Health and Clinical Excellence. Atrial fibrillation.

http://www.farmaka.be/fr/formu (...) (...) [HTML]

Boode BSP, Heeringa J, Konings KTS et al. NHG-Standaard Atriumfibrilleren.

http://www.farmaka.be/fr/formu (...) (...) [HTML]

http://www.farmaka.be/nl/wzc_f (...) [HTML]

Anderen hebben gezocht naar : primary care clinical national health health and clinical institute for health clinical preventive health prodigy klinical department of health pubmed clinical recherche dans washington health jour – clinical minerva – health postmenopausal osteoporosis clinical zoledronic acid technologies in health insititute for health clinical and health

datacenter (12): www.wordscope.be (v4.0.br)

clinical and health ->

Date index: 2024-06-03